Health, Fitness & Food

In this article Follow your favorite stocksCREATE FREE ACCOUNT Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson‘s consumer health

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable

In this article GSK-GB GSK Follow your favorite stocksCREATE FREE ACCOUNT A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Thursday reported first-quarter results that beat earnings and revenue expectations, but the company lowered its full-year profit guidance due to costs related to

In this article GILD Follow your favorite stocksCREATE FREE ACCOUNT Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Gilead Sciences and the U.S. government faced

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021. Soumyabrata Roy | NurPhoto | Getty Images Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a decline in sales driven

Alex Huth (left), Shailee Jain (center) and Jerry Tang (right) prepare to collect brain activity data in the Biomedical Imaging Center at The University of Texas at Austin. The researchers trained their semantic decoder on dozens of hours of brain activity data from participants, collected in an fMRI scanner.  Photo: Nolan Zunk/University of Texas at

In this article DGX LLY BIIB 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they

In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite

Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli Lilly‘s first-quarter earnings missed expectations Thursday, but the pharmaceutical company raised its full-year guidance. Before the

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters Patients who took Eli Lilly‘s weight loss drug tirzepatide lost

In this article ILMN IEP Follow your favorite stocksCREATE FREE ACCOUNT Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed the DNA sequencing company’s new plans to cut costs.  The activist investor, who owns

In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. Anna Moneymaker | Getty Images The abortion pill mifepristone is either banned or restricted to varying degrees in 27 states despite a Supreme Court decision that — for now — maintains Food and

Activists for transgender rights gather in front of the US Supreme Court in Washington, DC, on April 1, 2023. Andrew Caballero-reynolds | AFP | Getty Images The Department of Justice is suing Tennessee for allegedly discriminating against transgender youth with a new state law banning the use of puberty blockers, hormones, and other medical procedures

Former Theranos CEO Elizabeth Holmes on November 18, 2022 in San Jose, California. Justin Sullivan | Getty Images Disgraced Theranos founder Elizabeth Holmes will not go to prison this week, despite a judge’s order that she begin serving her 11-year sentence on Thursday. Late Tuesday, Holmes’ attorneys appealed that ruling to the U.S. 9th Circuit

Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images Medicare will cover the new Alzheimer’s treatment Leqembi for all patients eligible under the medication’s label

In this article ILMN Follow your favorite stocksCREATE FREE ACCOUNT A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters Illumina on Tuesday unveiled plans to cut costs in a bid to improve the DNA sequencing company’s shrinking margins. The plans

In this article LLY BIIB Follow your favorite stocksCREATE FREE ACCOUNT A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen isn’t worried about competing with Eli Lilly as they both attempt to bring an Alzheimer’s drug to the market, Biogen’s CEO

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Johnson & Johnson products for sale in New York. Scott Mlyn | CNBC Johnson & Johnson will price shares of its consumer health spinoff Kenvue at $20 to $23 in an initial public offering later this year, the company said in a regulatory filing Monday.

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Johnson & Johnson logo SOPA Images | LightRocket | Getty Images Johnson & Johnson‘s consumer health business is valued at $40 billion ahead of its initial public offering later this year, according to a report by The Wall Street Journal.  The soon-to-be spinoff Kenvue aims